Weight Management & Metabolism

Retatrutide

Triple-pathway agonist

FromAED

Prefilled PenInjectableCompound

A premier metabolic solution offering potent anti-obesity effects through triple-pathway support, enhancing satiety while preserving lean mass.

IndicationsObesity, weight management, metabolic syndrome

MechanismTriple monoamine receptor pathway activation

RouteSubcutaneous injection

DurationWeekly, dose titrated

Key Benefits

Potent anti-obesity effects
Enhanced satiety & reduced food intake
Preserves lean muscle during fat loss
Increased energy expenditure

Enquire about Retatrutide

Tesamorelin

GHRH analog

FromAED

InjectableCompound

A synthetic analog of growth hormone-releasing hormone that stimulates the pituitary to release natural growth hormone in a more natural rhythm.

IndicationsVisceral fat reduction, GH & IGF-1 support

MechanismGHRH analog stimulating pulsatile GH release

RouteSubcutaneous injection

Duration5–6 days/week at bedtime, 4–8 wk breaks

Key Benefits

Elevates IGF-1 levels
Reduces visceral and subcutaneous fat
Supports lean muscle mass
Improves cognitive function

Enquire about Tesamorelin

AOD-9604

GH fragment 176-191

FromAED

InjectableCompound

A modified fragment of growth hormone that stimulates lipolysis and supports a balanced metabolism, targeting stubborn adipose tissue without affecting blood sugar.

IndicationsTargeted fat loss, metabolic balance

MechanismStimulates lipolysis & inhibits lipogenesis

RouteSubcutaneous injection

DurationOnce daily, cycled

Key Benefits

Stimulates lipolysis (fat breakdown)
Targets stubborn adipose tissue
Supports a balanced metabolism
Does not impact blood sugar or appetite

Enquire about AOD-9604

MOTS-C

Mitochondrial-derived peptide

FromAED

InjectableCompound

A mitochondrial-derived peptide that regulates energy balance and metabolic health, enhancing glucose uptake and supporting cellular stress resistance.

IndicationsMetabolic health, insulin sensitivity, aging

MechanismRegulates energy balance at the mitochondrial level

RouteSubcutaneous injection

Duration5–6 days/week at bedtime, 4–8 wk breaks

Key Benefits